Why is it so difficult for GPs to effectively manage patients with rare skin diseases?


Journal

Presse medicale (Paris, France : 1983)
ISSN: 2213-0276
Titre abrégé: Presse Med
Pays: France
ID NLM: 8302490

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 01 01 2019
revised: 11 08 2019
accepted: 21 09 2019
pubmed: 24 11 2019
medline: 26 12 2019
entrez: 24 11 2019
Statut: ppublish

Résumé

Rare diseases are defined by a prevalence of less than one out of 2000 persons. In clinical practice, their management is difficult, due to their diversity, their complexity and a lack of adapted physician training. The aims of this study were to identify rare skin diseases in a reference center, to describe the difficulties encountered by general practitioners (GPs) in management of these uncommon cases, and to pinpoint the characteristics of the GPs having the most problems. A survey conducted from March to June 2017 involving GPs at least one of whose rare skin disease patients was being monitored in a reference center. All in all, 96/195 (49.2%) of the GPs contacted completed the questionnaire, and virtually all of them (95%) reported five main categories of difficulties: giving a diagnosis, monitoring treatment, coordinating care, providing support, and ensuring management of intercurrent pathologies. The most widely reported difficulties were related to diagnosis (88.5%) and care coordination (76%). The GPs most in need of assistance were those practicing in rural areas (11 times more likely to experience difficulties), those with over 10 years of experience (up to 9.8 times more risk) and those not considering their role in the management of patients with rare diseases as instrumental (2.28 times more risk). This study brought to light the difficulties encountered by GPs in management of patients with rare skin diseases. We identified those the most in need of assistance, who are to be targeted for actions aimed at improving the care and treatment of patients suffering from rare skin diseases.

Sections du résumé

BACKGROUND BACKGROUND
Rare diseases are defined by a prevalence of less than one out of 2000 persons. In clinical practice, their management is difficult, due to their diversity, their complexity and a lack of adapted physician training.
OBJECTIVE OBJECTIVE
The aims of this study were to identify rare skin diseases in a reference center, to describe the difficulties encountered by general practitioners (GPs) in management of these uncommon cases, and to pinpoint the characteristics of the GPs having the most problems.
METHODS METHODS
A survey conducted from March to June 2017 involving GPs at least one of whose rare skin disease patients was being monitored in a reference center.
RESULTS RESULTS
All in all, 96/195 (49.2%) of the GPs contacted completed the questionnaire, and virtually all of them (95%) reported five main categories of difficulties: giving a diagnosis, monitoring treatment, coordinating care, providing support, and ensuring management of intercurrent pathologies. The most widely reported difficulties were related to diagnosis (88.5%) and care coordination (76%). The GPs most in need of assistance were those practicing in rural areas (11 times more likely to experience difficulties), those with over 10 years of experience (up to 9.8 times more risk) and those not considering their role in the management of patients with rare diseases as instrumental (2.28 times more risk).
CONCLUSIONS CONCLUSIONS
This study brought to light the difficulties encountered by GPs in management of patients with rare skin diseases. We identified those the most in need of assistance, who are to be targeted for actions aimed at improving the care and treatment of patients suffering from rare skin diseases.

Identifiants

pubmed: 31757737
pii: S0755-4982(19)30490-7
doi: 10.1016/j.lpm.2019.09.061
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e382-e388

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Muriel Baqué (M)

Toulouse University Hospital, Department of Dermatology, 31059 Toulouse cedex 09, France.

Hélène Colineaux (H)

Toulouse University 11 Hospital, Department of Epidemiology, Health Economics and Public Health, 31000 Toulouse, France.

Isabelle Dreyfus (I)

University Toulouse III, LEASP UMR1027, Inserm-12, 31000 Toulouse, France.

Pierre Mesthé (P)

Toulouse University Hospital, Department of General Physicians, 31000 Toulouse, France.

Juliette Mazereeuw-Hautier (J)

Toulouse University Hospital, Referral Centre for Rare Skin Diseases, Department of Dermatology, 31059 Toulouse cedex 09, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH